The robust, sensitive, and selective detection of targeted biomolecules in their native
environment by prospective nanostructures holds much promise for real-time, accurate, and …

Point-of-care testing (POCT) is necessary to provide a rapid diagnostic result for a prompt on-
site diagnosis and treatment. A quick analysis time and high sensitivity, with a sample-to …

The COVID-19 pandemic has highlighted the importance and urgent need for rapid and
accurate diagnostic tests for COVID-19 detection and screening. The objective of this work …

The design and application of sensors for monitoring biomolecules in clinical samples is a
common goal of the sensing research community. Surface plasmon resonance (SPR) and …

Developing blood-based tests is appealing for non-invasive disease diagnosis, especially
when biopsy is difficult, costly, and sometimes not even an option. Tumor-derived exosomes …

We review point-of-care (POC) diagnostics, in vitro diagnostic (IVD) tests that do not involve
the use of laboratory staff and facilities to provide the result. The analytical “targets” include …

The development of passively driven microfluidic labs on chips has been increasing over the
years. In the passive approach, the microfluids are usually driven and operated without any …

Tumor-derived circulating exosomes, enriched with a group of tumor antigens, have been
recognized as a promising biomarker source for cancer diagnosis via a less invasive …

Targeted mass spectrometry (MS) is becoming widely used in academia and in
pharmaceutical and biotechnology industries for sensitive and quantitative detection of …

Microfluidic systems have shown unequivocal performance improvements over conventional
bench-top assays across a range of performance metrics. For example, specific advances …